B7-H3: a promising target for immunotherapy in glioma.

Saved in:
Bibliographic Details
Title: B7-H3: a promising target for immunotherapy in glioma.
Authors: Feng XL; Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China., Su G; Institute of Genetics, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China., Jia Q; Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China., Wu QH; Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China., Zhang ZC; Lanzhou University Second Hospital, Lanzhou University, Lanzhou, China. tougao13893647595@163.com.
Source: Discover oncology [Discov Oncol] 2025 Oct 31; Vol. 16 (1), pp. 1998. Date of Electronic Publication: 2025 Oct 31.
Publication Type: Journal Article
Journal Info: Publisher: Springer Country of Publication: United States NLM ID: 101775142 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-6011 (Electronic) Linking ISSN: 27306011 NLM ISO Abbreviation: Discov Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2730-6011
DOI:10.1007/s12672-025-03328-y